- Department of Cellular Biology, Histology and Pharmacology, Faculty of Health Sciences, University of Valladolid, Campus of Soria, 42003 Soria, Spain,Neurobiology Research Group, Faculty of Medicine, University of Valladolid, 47005 Valladolid, SpainInterests: Precision medicine; Genotype; Precision oncology; Cancer; Liquid biopsy; Cancer detection; Clinical practice; Translational oncologySpecial Issues and Topics in IMR Press journalsSpecial Issue in Exercise Physiology and Sport Performance
In recent years there has been an increase in the knowledge of cancer, accompanied by a technological development that has given rise to medical oncology. technological development resulting in Precision Medicine (PM). PM is a course of treatment designed specifically for an individual patient or subpopulation based on a particular genotype or specific biomarkers that might be indicative of the course of the disorder. Precision medicine uses novel biomarkers, targeted disease mechanisms, pharmacogenomics and pharmacogenetics for early diagnosis, appropriate treatment selection, monitoring of response to therapy, progression and prognosis. Its role in disease diagnosis, management, monitoring and prognosis has become more important in recent years due to the rise of omics fields, such as proteomics, metabolomics, genomics and transcriptomics, which have allowed PM to establish reliability. as a developing domain. The use of new biomarkers in cancer disease has allowed individualized therapies and prognostics to become more prevalent, increasing the accuracy of diagnostics and the efficacy of PM-based interventions.
Dr. Diego Fernández Lázaro
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted manuscripts should be well formatted in good English.
- Genetic Alterations of C-MYC Proto-Oncogene and Their Involvement in the Occurrence and Progression of Oral Cavity Cancers in SenegalDiao Ba, Fatimata Mbaye, Henri Diatta, Mame Diarra Samb, ... Mbacke SembeneJ. Mol. Clin. Med. 2023, 6(1), 2; https://doi.org/10.31083/j.jmcm0601002(This article belongs to the Special Issue Cancer Precision Medicine)19Downloads69Views